Abstract
The background prevalence of microagglutination antibodies to Legionella pneumophila was determined by testing the sera of 517 individuals who lived or worked in a small Iowa town. In this population, the upper limit of normal microagglutination titer for serogroups 1, 3, and 4 was 1:16, and that for serogroup 2 was 1:8. The prevalence of microagglutination titers of greater than or equal to 1:32 against any serogroup of L. pneumophila was only 7.4% and did not vary significantly with age or sex.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Farshy C. E., Klein G. C., Feeley J. C. Detection of antibodies to legionnaires disease organism by microagglutination and micro-enzyme-linked immunosorbent assay tests. J Clin Microbiol. 1978 Apr;7(4):327–331. doi: 10.1128/jcm.7.4.327-331.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hébert G. A., Moss C. W., McDougal L. K., Bozeman F. M., McKinney R. M., Brenner D. J. The rickettsia-like organisms TATLOCK (1943) and HEBA (1959): bacteria phenotypically similar to but genetically distinct from Legionella pneumophila and the WIGA bacterium. Ann Intern Med. 1980 Jan;92(1):45–52. doi: 10.7326/0003-4819-92-1-45. [DOI] [PubMed] [Google Scholar]
- Klein G. C., Baker C. N., Jones W. L. "Upper limits of normal" antistreptolysin O and antideoxyribonuclease B titers. Appl Microbiol. 1971 Jun;21(6):999–1001. doi: 10.1128/am.21.6.999-1001.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klein G. C., Jones W. L., Feeley J. C. Upper limit of normal titer for detection of antibodies to Legionella pneumophila by the microagglutination test. J Clin Microbiol. 1979 Nov;10(5):754–755. doi: 10.1128/jcm.10.5.754-755.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wong K. H., Schalla W. O., Arko R. J., Bullard J. C., Feeley J. C. Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine. Ann Intern Med. 1979 Apr;90(4):634–638. doi: 10.7326/0003-4819-90-4-634. [DOI] [PubMed] [Google Scholar]
